Table 1 showed the initial characteristics of each patient, such as age, sex, primary site, metastasis sites, baseline CA19‐9, baseline CEA, baseline SII, baseline MLR, baseline NLR, BMI, history of diabetes, history of smoking, history of drinking and systemic chemotherapy regimen. The gene discussed is CEACAM5; the disease is diabetes mellitus.